Drive your sustainability strategy by assessing your scope 3 emissions!
Drive your sustainability strategy by assessing your scope 3 emissions!
Driving commercial expansion at pharma companies
As pharma start-ups mature from R&D organisations into commercial ventures, they need to establish governance, controls and disciplines across their operations. John Mason, Manufacturing & Engineering Services Partner at Curzon Consulting explores market expansion and operating model maturity.
Market expansion
Pharma companies should deploy a scalable and repeatable go-to-market approach to guide, accelerate and assure commercial expansion.
The benefits are:
- Identify, manage and reduce operational, commercial and regulatory risk
- Independent review and challenge of expansion plans and strategies
- Decrease duplication, rework and capability gaps
Operating model maturity
Reduce compliance and performance risks through improved governance, controls and disciplines across the footprint. The benefits include:
- Clarity on investment priorities
- Standardised, effective and efficient ways of working
- Rapid deployment of back office services
- Simplified data and systems landscapes
Programme management
Deploy robust disciplines, tools and capabilities to drive efficient and effective commercial expansion programme. The benefits are:
- Balance agile ways of working with quality, discipline and challenge to optimise outcomes
- Access tried and tested programme management toolkit and capabilities
- Grow organisational skills and capabilities
Contact us to explore how to drive market expansion and operating model maturity.
